High Coverage of Mass Drug Administration for Lymphatic Filariasis in Sierra Leone
Author Information
Author(s): Hodges Mary H, Smith Samuel J, Fussum Daniel, Koroma Joseph B, Conteh Abdul, Sonnie Mustapha, Zhang Yaobi
Primary Institution: Helen Keller International
Hypothesis
Can a modified mass drug administration strategy achieve high coverage for lymphatic filariasis treatment in rapidly growing urban and rural settings?
Conclusion
The study demonstrates that a coordinated social mobilization strategy can achieve high coverage for lymphatic filariasis treatment in urban and rural areas.
Supporting Evidence
- 1,104,407 eligible persons were treated during the campaign.
- Coverage was reported as 116% in the Urban Western Area and 129% in the Rural Western Area.
- 85.8% of interviewees recalled taking both ivermectin and albendazole.
Takeaway
This study shows that a lot of people in Sierra Leone got treated for a disease called lymphatic filariasis thanks to a well-organized campaign that used both traditional and modern ways to share information.
Methodology
The study used independent monitoring with interviews to assess treatment coverage during a 5-day mass drug administration campaign.
Potential Biases
Potential bias in self-reported treatment recall and the use of census data that may not represent the current population accurately.
Limitations
The study relied on projected population data from 2004, which may not accurately reflect the current population due to rapid growth.
Participant Demographics
Participants included eligible persons in both urban and rural areas of the Western Area, Sierra Leone.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website